Drug-Eluting Balloons Are Coming, But Are We Ready?

Affiliations

¹ Cardiology Department, European Hospital Georges Pompidou, Assistance Publique Hôpitaux de Paris, Paris University and Sudden Cardiac Death Expert Center, Paris, France. Electronic address: christian.spaulding@aphp.fr.

Editorial

Christian Spaulding. Cardiovasc Revasc Med. 2022 Feb.

. 2022 Feb:35:83-84.

doi: 10.1016/j.carrev.2021.11.020. Epub 2021 Nov 20.

¹ Cardiology Department, European Hospital Georges Pompidou, Assistance Publique Hôpitaux de Paris, Paris University and Sudden Cardiac Death Expert Center, Paris, France. Electronic address: christian.spaulding@aphp.fr.

No abstract available

Conflict of interest statement

Declaration of competing interest Consultant for MedAlliance, Medtronic, Edwards, Techwald.

Outcomes With Drug-Coated Balloons vs. Drug-Eluting Stents in Small-Vessel Coronary Artery Disease.
Megaly M, Buda K, Saad M, Tawadros M, Elbadawi A, Basir M, Abbott JD, Rinfret S, Alaswad K, Brilakis ES. Megaly M, et al. Cardiovasc Revasc Med. 2022 Feb;35:76-82. doi: 10.1016/j.carrev.2021.03.008. Epub 2021 Mar 20. Cardiovasc Revasc Med. 2022. PMID: 33858783